Old Web
English
Sign In
Acemap
>
Paper
>
PO-1793: BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial
PO-1793: BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial
2020
Maaike Berbee
Thirza Opbroek
J. Paulissen
R Houben
E. Van Limbergen
B Ta
I. Steenbakkers
Frans Verhaegen
R. de Ridder
R Jansen
Jarno Melenhorst
Frans C. H. Bakers
Heike I. Grabsch
Jeroen Buijsen
R. Canters
Keywords:
Radiology
Medicine
Colorectal cancer
Fiducial marker
Boosting (machine learning)
Radiation therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]